Consequences of adiponectin deficiency: Can they be related to the pathophysiology of laminitis?

1. Elliott J, Bailey SR. A review of cellular and molecular mechanisms in endocrinopathic, sepsis-related and supporting limb equine laminitis.. Equine Vet J 2023;55(3):350-75.
   doi: 10.1111/evj.13933google scholar: lookup
2. Wang ZV, Scherer PE. Adiponectin, the past two decades.. J Mol Cell Biol 2016;8(2):93-100.
3. Fang H, Judd RL. Adiponectin regulation and function.. Compreh Physiol 2018;8(3):1031-63.
4. Rodríguez C, Muñoz M, Contreras C, Prieto D. AMPK, metabolism, and vascular function.. FEBS J 2021;288(12):3746-71.
5. Inoki K, Kim J, Guan KL. AMPK and mTOR in cellular energy homeostasis and drug targets.. Annu Rev Pharmacol Toxicol 2021;52:381-400.
6. Burns TA, Watts MR, Weber PS, McCutcheon LJ, Geor RJ, Belknap JK. Effect of dietary nonstructural carbohydrate content on activation of 5′-adenosine monophosphate-activated protein kinase in liver, skeletal muscle, and digital laminae of lean and obese ponies.. J Vet Intern Med 2014;28(4):1280-8.
7. Teoh H, Quan A, Bang KW, Wang G, Lovren F, Vu V. Adiponectin deficiency promotes endothelial activation and profoundly exacerbates sepsis-related mortality.. Am J Physiol Endocrinol Metab 2008;295(3):E658-64.
8. Tsujimura Y, Matsutani T, Matsuda A, Kutsukake M, Uchida E, Sasajima K. Effects of pioglitazone on survival and omental adipocyte function in mice with sepsis induced by cecal ligation and puncture.. J Surg Res 2011;171(2):e215-21.
9. Hou Y, Wang XF, Lang ZQ, Zhao W, Jin Y, Zhang HQ. Adiponectin alleviates blood hypercoagulability via inhibiting endothelial cell apoptosis induced by oxidative stress in septic rats.. Iran J Basic Med Sci 2018;21(10):1013-9.
10. Liu L-J, Xu M, Zhu J, Li N, Zhao X-Z, Gao H-M. Adiponectin alleviates liver injury in sepsis rats through AMPK/MTOR pathway.. Eur Rev Med Pharmacol Sci 2020;24(20):10745-52.
11. Hillenbrand A, Xu P, Zhou S, Blatz A, Weiss M, Hafner S. Circulating adipokine levels and prognostic value in septic patients.. J Inflamm (Lond) 2016;13(1):30.
12. Karampela I, Kandri E, Antonakos G, Vogiatzakis E, Christodoulatos GS, Nikolaidou A. Kinetics of circulating fetuin-A may predict mortality independently from adiponectin, high molecular weight adiponectin and prognostic factors in critically ill patients with sepsis: a prospective study.. J Crit Care 2017;41:78-85.
13. Zheng X, Liu D. Adiponectin alleviates the symptoms of ischemic renal disease by inhibiting renal cell apoptosis.. Life Sci 2021;265:118825.
14. Faleiros RR, Stokes AM, Eades SC, Kim DY, Paulsen DB, Moore RM. Assessment of apoptosis in epidermal lamellar cells in clinically normal horses and those with laminitis.. Am J Vet Res 2004;65(5):578-85.
15. Fu S, Xu H, Gu M, Liu C, Wang Q, Wan X. Adiponectin deficiency contributes to the development and progression of benign prostatic hyperplasia in obesity.. Sci Rep 2017;7:43771.
16. Cassimeris L, Engiles JB, Galantino-Homer H. Detection of endoplasmic reticulum stress and the unfolded protein response in naturally-occurring endocrinopathic equine laminitis.. BMC Vet Res 2019;15(1):24.
17. Mohan S, Preetha Rani MR, Brown L, Ayyappan P, Ragu KG. Endoplasmic reticulum stress: a master regulator of metabolic syndrome.. Eur J Pharmacol 2019;860:172553.
18. Sharma K, Ramachandrarao S, Qiu G, Usui HK, Zhu Y, Dunn SR. Adiponectin regulates albuminuria and podocyte function in mice.. J Clin Invest 2008;118(5):1645-56.
19. Kampe K, Sieber J, Orellana JM, Mundel P, Jehle AW. Susceptibility of podocytes to palmitic acid is regulated by fatty acid oxidation and inversely depends on acetyl-CoA carboxylases 1 and 2.. Am J Physiol Renal Physiol 2014;306(4):F401-9.
20. Goldstein BJ, Scalia R. Adipokines and vascular disease in diabetes.. Curr Diab Rep 2007;7(1):25-33.
21. Goldstein BJ, Scalia RG, Ma XL. Protective vascular and myocardial effects of adiponectin.. Nat Clin Pract Cardiovasc Med 2009;6(1):27-35.
22. Wang H, Wu W, Duan J, Ma M, Kong W, Ke Y. Cardioprotection of ischemic preconditioning in rats involves upregulating adiponectin.. J Mol Endocrinol 2017;58(4):155-65.
23. Almabrouk TA, Ewart MA, Salt IP, Kennedy S. Perivascular fat, AMP-activated protein kinase and vascular diseases.. Br J Pharmacol 2014;171(3):595-617.
24. Liu B, Liu J, Wang J, Sun F, Jiang S, Hu F. Adiponectin protects against cerebral ischemic injury through AdipoR1/AMPK pathways.. Front Pharmacol 2019;10:597.
25. Cheng CF, Lian WS, Chen SH, Lai PF, Li HF, Lan YF. Protective effects of adiponectin against renal ischemia-reperfusion injury via prostacyclin-PPARalpha-heme oxygenase-1 signaling pathway.. J Cell Physiol 2012;227(1):239-49.
26. Chen J, Zhang W, Wu YQ, Chen H, Zhao JF. Correlations of acute myocardial infarction complicated by cerebral infarction with insulin resistance, adiponectin and HMGB1.. Eur Rev Med Pharmacol Sci 2019;23(10):4425-31.
27. Rodríguez C, Sánchez A, Sáenz-Medina J, Muñoz M, Hernández M, López M. Activation of AMP kinase ameliorates kidney vascular dysfunction, oxidative stress and inflammation in rodent models of obesity.. Br J Pharmacol 2021;178(20):4085-103.
28. Venugopal CS, Eades S, Holmes EP, Beadle RE. Insulin resistance in equine digital vessel rings: an in vitro model to study vascular dysfunction in equine laminitis.. Equine Vet J 2011;43(6):744-9.
29. Morgan RA, Keen JA, Walker BR, Hadoke PW. Vascular dysfunction in horses with endocrinopathic laminitis.. PLoS One 2016;11(9):e0163815.
30. Hood DM, Grosenbaugh DA, Mostafa MB, Morgan SJ, Thomas BC. The role of vascular mechanisms in the development of acute equine laminitis.. J Vet Intern Med 1993;7(4):228-34.
31. Gardner AK, van Eps AW, Watts MR, Burns TA, Belknap JK. A novel model to assess lamellar signaling relevant to preferential weight bearing in the horse.. Vet J 2017;221:62-7.
32. van Eps AW, Belknap JK, Schneider X, Stefanovski D, Engiles JB, Richardson DW. Lamellar perfusion and energy metabolism in a preferential weight bearing model.. Equine Vet J 2021;53(4):834-44.

Citations